Texas Tech Obstetrics & Gynecology 1400 S Coulter St FL 3, Amarillo, TX 79106 (806)4149707 (phone), (806)3545626 (fax)
Texas Technician University Obstetrics & Gynecology 1400 S Coulter St FL 3, Amarillo, TX 79106 (806)4149650 (phone), (806)3545626 (fax)
Education:
Medical School University of Texas Medical School at Houston Graduated: 1979
Procedures:
Electrocardiogram (EKG or ECG) Hysterectomy Myomectomy Tubal Surgery Vaccine Administration Vaginal Delivery
Conditions:
Conditions of Pregnancy and Delivery Endometriosis Abnormal Vaginal Bleeding Breast Disorders Candidiasis of Vulva and Vagina
Languages:
English Spanish
Description:
Dr. Kauffman graduated from the University of Texas Medical School at Houston in 1979. He works in Amarillo, TX and 1 other location and specializes in Obstetrics & Gynecology. Dr. Kauffman is affiliated with BSA Hospital and The Pavilion Northwest Texas Healthcare System.
Fortress was founded in 1998 by Edens, Nardone and Robert Kauffman, who came from Swiss bank UBS AG and New York-based BlackRock Financial Management Inc.Briger was hiredfrom Goldman Sachs Group Inc. in 2002. The three founders became billionaires when the fund went public in the first IPO by a pr
"Bacteriatendsto stay ahead of antibiotics and develop their own resistance," said Dr. Robert Kauffman, Director of Reproductive Medicine and Infertility at TTUHSC."What we're starting to see now is that gonorrhea may become relatively resistant to the first line drug which is [called] ceftriaxon
Date: Jul 15, 2016
Category: Health
Source: Google
College football: Walter Camp Player of the Year announces watch list
We are proud to continue the great work of Walter Camp and recognize the best college football players in the nation, Foundation president Robert Kauffman said. This watch list is a great start to what is shaping up to be another exciting year of college football.
utation did not meet its primary endpoint, we are encouraged by the significant improvements in lung function and other measures of CF observed in the subset of patients ages 18 and older who had established lung disease, Dr. Robert Kauffman,chief medical officer at Vertex, said in a statement.
Date: Dec 20, 2013
Category: Health
Source: Google
Vertex Announces Results of Phase 3 Study of Ivacaftor in People with CF who ...
"With each study of ivacaftor, we continue to learn more about this disease and the effect of ivacaftor in patients with different CF mutations, ages and severity of disease," said Robert Kauffman, M.D., Ph.D., Senior Vice Presiden
Date: Dec 19, 2013
Category: Health
Source: Google
Vertex updates label of hepatitis C drug after reports of a 'small number of fatal ...
In a statement, Vertex senior vice president and chief medical officer Robert Kauffman, MD., said: The safety of people taking our medicines is our first priority, and we are committed to ensuring that patients and physicians are aware of the label update to help them use Incivek properly. We will
Date: Dec 19, 2012
Category: Health
Source: Google
Vertex, GSK partner for Phase 2 all-oral hepatitis C study
Vertex senior vice president and chief medical officer Robert Kauffman said the agreement underscores the company's commitment to develop all-oral treatment regimens for people with hepatitis C using medicines within our own pipeline and by working in collaboration with other companies like GSK.
Date: Nov 02, 2012
Category: Health
Source: Google
Vertex partners with J&J, GlaxoSmithKline on new hep C combos
"We are focused on the development of new all-oral treatments for hepatitis C that have the potential to provide a high cure rate with only 12 weeks of treatment, and we look forward to the start of this study with GSK," said Robert Kauffman, Vertex's chief medical officer.